Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Stock Short Interest Falls 58.7%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totaling 161,919 shares, a decline of 58.7% from the August 31st total of 391,908 shares. Currently, 9.0% of the company’s shares are sold short. Based on an average daily trading volume, of 251,471 shares, the short-interest ratio is currently 0.6 days.

Defiance Daily Target 2X Long LLY ETF Price Performance

LLYX stock traded down $0.07 during mid-day trading on Tuesday, reaching $25.66. The company had a trading volume of 165,061 shares, compared to its average volume of 425,889. The firm has a 50 day moving average of $25.87 and a 200 day moving average of $23.00. Defiance Daily Target 2X Long LLY ETF has a 12 month low of $12.58 and a 12 month high of $31.19.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.